Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrous Sulfate/Ferrous Succinate + Serplulimab + SOX in Neoadjuvant Therapy for Gastric Cancer
NCT07872696Phase 2Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ferrous sulfate, ferrous succinate in gastric cancer (GC). Planned start Sep 2026; status: not yet recruiting.
02
Drugs
ferrous sulfateferrous succinate
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07872696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07872696.